GlaxoSmithKline does not know when it will resume producing Excedrin. Pharmaceutical giant GlaxoSmithKline has temporarily stopped production of Excedrin, its popular over-the-counter migraine ...

AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...

Glaxosmithkline, with multiple operations in Montco, just scored a major regulatory win that could reshape how lupus ...

GlaxoSmithKline said it would buy cancer-focused drug company Tesaro for about $4.16 billion, positioning the health-care giant in a promising, but fiercely competitive, area of medicine.

This morning, GlaxoSmithKline announced a $3 billion criminal settlement with the Department of Justice to settle accusations that it didn't tell regulators about safety problems with an infamous ...

Democratic U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's decision to discontinue a widely used asthma inhaler for ...

GlaxoSmithKline, which is based in London, was formed on Jan. 1, 2001 by the $76 billion merger of Glaxo Wellcome, the maker of Wellbutrin (depression) and Imitrex (migraines), ...

Photo by Flickr user Ian Wilson Doctors will no longer be paid to speak on behalf of GlaxoSmithKline and its products, the British drug maker said Tuesday. In addition, the pharmaceutical company ...

GlaxoSmithKline downgraded full-year earnings expectations, as its second-quarter profit was hit by currency moves, weak sales of its respiratory drugs and the continuing bribery investigation in ...

GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster ...

GlaxoSmithKline PLC Leadership Team Success. GlaxoSmithKline PLC leaders and executives have shown their dedication by being a leading pharmaceutical company and research and development firm.

GlaxoSmithKline officials on Thursday did not immediately respond to a request for comment. Until it was discontinued in 2023, Flovent was one of the most widely prescribed asthma medications in ...